Shaw GL - Search Results

1

The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype.

Caporaso NE, Shields PG, Landi MT, Shaw GL, Tucker MA, Hoover R, Sugimura H, Weston A, Harris CC. Caporaso NE, et al. Among authors: shaw gl. Environ Health Perspect. 1992 Nov;98:101-5. doi: 10.1289/ehp.9298101. Environ Health Perspect. 1992. PMID: 1362537 Free PMC article.

2

Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.

Sugimura H, Caporaso NE, Shaw GL, Modali RV, Gonzalez FJ, Hoover RN, Resau JH, Trump BF, Weston A, Harris CC. Sugimura H, et al. Among authors: shaw gl. Carcinogenesis. 1990 Sep;11(9):1527-30. doi: 10.1093/carcin/11.9.1527. Carcinogenesis. 1990. PMID: 1976046

3

Effect of diurnal variation on debrisoquine metabolic phenotyping.

Shaw GL, Falk RT, Caporaso NE, Issaq HJ, Kase RG, Fox SD, Tucker MA. Shaw GL, et al. J Natl Cancer Inst. 1990 Oct 3;82(19):1573-5. doi: 10.1093/jnci/82.19.1573. J Natl Cancer Inst. 1990. PMID: 2402018 No abstract available.

4

Debrisoquine metabolism and lung cancer risk.

Shaw GL, Falk RT, Deslauriers J, Frame JN, Nesbitt JC, Pass HI, Issaq HJ, Hoover RN, Tucker MA. Shaw GL, et al. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):41-8. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7894323

5

Clinical implications of the competitive inhibition of the debrisoquin-metabolizing isozyme by quinidine.

Caporaso NE, Shaw GL. Caporaso NE, et al. Among authors: shaw gl. Arch Intern Med. 1991 Oct;151(10):1985-92. Arch Intern Med. 1991. PMID: 1681790 Review.

6

Problems ascertaining friend controls in a case-control study of lung cancer.

Shaw GL, Tucker MA, Kase RG, Hoover RN. Shaw GL, et al. Am J Epidemiol. 1991 Jan;133(1):63-6. doi: 10.1093/oxfordjournals.aje.a115803. Am J Epidemiol. 1991. PMID: 1845760

7

Lung tumor resection does not affect debrisoquine metabolism.

Shaw GL, Falk RT, Deslauriers J, Nesbitt JC, McKneally MF, Frame JN, Feld R, Issaq HJ, Ruckdeschel JC, Hoover RN. Shaw GL, et al. Cancer Epidemiol Biomarkers Prev. 1994 Mar;3(2):141-4. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8049635

8

Genetic polymorphism of CYP2D6 and lung cancer risk.

Shaw GL, Falk RT, Frame JN, Weiffenbach B, Nesbitt JC, Pass HI, Caporaso NE, Moir DT, Tucker MA. Shaw GL, et al. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):215-9. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9521436

9

Age at onset for familial epithelial ovarian cancer.

Amos CI, Shaw GL, Tucker MA, Hartge P. Amos CI, et al. Among authors: shaw gl. JAMA. 1992 Oct 14;268(14):1896-9. JAMA. 1992. PMID: 1404714

10

Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls.

Shaw GL, Weiffenbach B, Falk RT, Frame JN, Issaq HJ, Moir DT, Caporaso N. Shaw GL, et al. Lung Cancer. 1997 May;17(1):61-8. doi: 10.1016/s0169-5002(97)00649-1. Lung Cancer. 1997. PMID: 9194027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters